Sarah (Bourgeois) Jacques
Upton,MA
Summary
Strategic, results-oriented commercial executive with 20 years of experience in the life sciences, specializing in rare disease therapy commercialization and international market expansion. Demonstrated success in launching and growing brands, revitalizing mature portfolios, and building trusted partnerships with KOLs and patient communities to drive sustained uptake. Recognized for delivering measurable business results, cross-functional leadership, and the ability to build and inspire high-performing teams that consistently surpass ambitious corporate objectives while advancing access to transformative therapies for patients worldwide.
Overview
15
15
years of professional experience
Work History
Vice President, Global Strategic Marketing
PTC Therapeutics
01.2023 - Current
- Leads a portfolio of innovative neurology and metabolic therapies, including overseeing the global launch of Sephience for PKU and orchestrating the global commercial strategy for TRANSLARNA and Upstaza/KEBILIDI
- Designs market strategies that enhance brand recognition, accelerate patient uptake, and drive business expansion across 20+ markets
- Manages $15M global marketing budget and prioritizes investments and resource allocation to maximize revenue aligned to corporate goals
- Oversees the planning and execution of all strategic internal/external events, including congresses, global brand planning, best practice/training summits and business planning meetings
- Leads a high-performing global marketing and events planning team of 25 professionals across 4 regions, including 10 direct reports, while mentoring 3 cross-functional directors expanding to global strategic roles
Executive Director, Global Strategic Marketing
PTC Therapeutics
04.2021 - 04.2023
- Led the cross-functional TRANSLARNA Commercial Team and orchestrated the strategy for geographical expansion and data communication in collaboration with Regulatory, Medical and Market Access
- Launched an updated TRANSLARNA HCP and patient campaign to communicate new data and to establish the need for early and ongoing treatment
- Spearheaded the development of an early stakeholder campaign to drive nmDMD early diagnosis
- Orchestrated a global stakeholder engagement plan during the EMA conditional approval to ensure consistent communication, resulting in 90% of EUR patients remaining on treatment
Senior Director, Global Strategic Marketing
PTC Therapeutics
11.2019 - 04.2021
- Directed TRANSLARNA global brand strategy, including HCP & patient engagement, congress strategy, and communication of key data
- Launched a new nmDMD disease awareness campaign to drive patient identification
- Collaborated with regional and country teams to execute TRANSLARNA launches in emerging markets, ensuring market readiness and maintaining brand consistency
- Spearheaded the expansion of VEEVA and digital capabilities to drive closed-loop marketing both globally and regionally
- Enhanced internal strategic processes, including global brand planning and publication communication planning, to ensure global and cross-functional alignment
Head of US Marketing for Established Products
SANOFI
12.2017 - 11.2019
- Led the brand management and promotional execution of prioritized products across the Established Products portfolio, including the management of the Multi-channel Engagement function
- Drove performance for Synvisc and Seprafilm to exceed 2019 goals of net sales $256M and $63M by driving pull-through of segmented customer profiling
- Developed targeted marketing capabilities for LCM initiatives to manage and optimize the value of Peri-LOE across US business units
- Led agency and external vendor relationships, including Contract Sales Organizations for Synvisc and Seprafilm
Director, Global Marketing LAL-D
ALEXION PHARMACEUTICALS
01.2015 - 01.2018
- Led the development of the disease educational platform driving disease awareness and patient identification
- Collaborated closely with Commercial Insights, Sales and Medical to further refine strategic market development
- Served as the Global Marketing lead for EMEA region to ensure alignment and support expansion
- Created all non-personal promotion, including eMarketing for both unbranded and branded campaigns
- Fostered relationships with LAL-D community stakeholders (KOLs, Patient Advocacy)
Associate Director, Commercial Program Management
SYNAGEVA BIOPHARMA
01.2014 - 01.2015
- Managed US and global launch of Kanuma, developing and overseeing the execution of cross-functional launch plans, monitoring key milestones, decisions, and risks while driving cross-functional alignment on key launch activities
Senior Consultant
COLLABORATIVE CONSULTING
01.2013 - 01.2014
- Provided management consulting services to mid-large size biopharmaceutical clients, including budget analysis, organizational design, data governance, resource planning, and project management
Senior Consultant
MAXIOM GROUP, INC.
01.2011 - 01.2013
- Designed and managed commercial launch plans with cross-functional teams to prepare mid-size biopharmaceutical companies to transform from a research organization to a commercial entity
Education
Master of Business Administration (MBA) -
Babson College, F.W. Olin Graduate School of Business
Wellesley, MA01.2011
Bachelor of Science (BS) - Biology
University of Massachusetts Amherst
Amherst, MA01.2003
Skills
- Strategic Marketing & Commercial Effectiveness
- Omnichannel Marketing & Stakeholder Engagement
- Global & US Product Launch
- Competitive Intelligence, Data Analytics
- Rare Disease Neurology & Metabolic Commercialization
- Portfolio Management & Budget ROI Optimization
- Cross-functional Leadership
Timeline
Vice President, Global Strategic Marketing
PTC Therapeutics
01.2023 - Current
Executive Director, Global Strategic Marketing
PTC Therapeutics
04.2021 - 04.2023
Senior Director, Global Strategic Marketing
PTC Therapeutics
11.2019 - 04.2021
Head of US Marketing for Established Products
SANOFI
12.2017 - 11.2019
Director, Global Marketing LAL-D
ALEXION PHARMACEUTICALS
01.2015 - 01.2018
Associate Director, Commercial Program Management
SYNAGEVA BIOPHARMA
01.2014 - 01.2015
Senior Consultant
COLLABORATIVE CONSULTING
01.2013 - 01.2014
Senior Consultant
MAXIOM GROUP, INC.
01.2011 - 01.2013
Bachelor of Science (BS) - Biology
University of Massachusetts Amherst
Master of Business Administration (MBA) -
Babson College, F.W. Olin Graduate School of Business